Dr. Avi Weisfogel has become a thought leader in advancing the science and craft of dentistry with innovative new techniques that address the common problem of sleep apnea. He has studied extensively sleep disorders and how dental implants can be helpful in their treatment. He is also at the forefront in teaching other dentists how they can begin treating sleep disorders in their own practice which helps them expand with new services.
Sleep apnea is a potentially life-threatening disorder which wreaks havoc on people in the short-term and reduces their quality of life overall. When one doesn’t get enough sleep their body’s restorative powers are markedly reduced as most of this work occurs during deep sleep. The characteristic pauses constantly interrupt healthy sleep and make for a tired look and a rundown feeling.
Dr. Weisfogel has devoted his career to helping patients overcome this problem and is a pioneer in utilizing dentistry to treat sleep disorders. This usually involves a custom-fitted dental appliance which ensures the patient’s airway stays open during sleep and it has the added benefit of preventing grinding of teeth.
The deep level of experience that Dr. Weisfogel brings to bear on the subject of dentistry and sleep disorders has put him in the unique position of an educator as well as a researcher and a specialist. His initiative, Healthy Heart Sleep, is how he collaborates with physicians and makes known to the medical community the advantages and possibilities of using dental devices.
Dental Sleep Masters is another one of his organizations that seeks to advance the role of dentistry in treating sleep disorders. It works with dentists so they fully understand the vital role they could play in improving the lives of their patients that are afflicted with sleep disorders. It is also a method used by them to expand their practices by offering new services.
Dr. Avi Weisfogel is a graduate of Rutgers University with degrees in Psychology and Biology. He received his credentials as a certified dentist from the College of Dentistry at New York University where he got his DDS. His unique work in dentistry has marked him as an innovator who constantly advances the science of the business.
While a whopping 29 million Americans have diabetes, one person in a group of four people is unaware that they have the disease. The number of individuals diagnosed with the disease rose from 26 million in 2010 to 29 million in 2012: a worrying trend. Americans are asked to visit medical facilities for medical check-ups because untreated diabetes is likely to lead to eye problems, dementia, and depression among other harmful medical conditions.
Residents of Asheboro, North Carolina, can visit Horizon Internal Medicine. A medical facility founded by Dr. Imran Haque to treat patients with medical conditions such diabetes, epilepsy, glaucoma, and pneumonia among other conditions. Dr. Haque founded Horizon on the premise that patients’ health and lives matter than any other interest of a medical practitioner. Dr. Haque is a licensed and experienced doctor with over 15 years in active practice. He is the physician of choice for many Asheboro residents because of the reputation he has built over the years.
Although there are different types of diabetes, type 2 diabetes is the most widespread. Statistics from Centre for Disease Control (CDC) indicate that 90% of Americans diagnosed with diabetes have type 2 diabetes. The various ways of managing type 2 diabetes are in the public domain; two management methods stand out: planning diet and frequent exercises. However, specialists including Dr. Imran encourage patients to work towards their health goals while under the supervision of a physician. The role of a doctor in supporting diabetes patients to attain their fitness goals and dispensing medical advice cannot be underestimated.
Horizon Internal Medicine is a trusted provider of health care in Asheboro, but there is more to the facility. Dr. Imran Haque is a forward-thinking professional who is ever concerned with using technology to sort out complicated health care issues. To this end, Horizon uses the latest technology in the diagnosis and treatment of various ailments.
Every patient strives to seek the most skilled dentist and health practitioner to take care of their health needs. As a result, most dentists work hard towards developing their skills to offer the best services to their patients at all cost. MB2 is one of the most organized groups of dentists who are highly skilled and focus on providing unique services to their clients. Besides, the company offers its team of employees with incentives such as holiday vacations to encourage them to bring out the best in their career.
Dr. Villanueva, the founder of the group, believes that the group has its own unique culture that targets to ensure a personal growth of all its individuals, support to every medical practitioner among others. Dr. Chris believes that the various trips offered to the medical expert’s forms part of their culture and targets towards developing their skills and equipping them with the necessary skills which they learn and share with each other. Besides, Dr. Chris believes that doctors tend to perform better in cases where they work together as a team instead of working on their own. He insists that breaks are an essential part of every doctor’s career as they help to ensure that they take a break away from the tiring work, and as a result develop better strategies to deal with the emerging issues in the health sector.
Besides, the founder of the group of doctors believes that the physician’s services and performance get to improve with time depending on the amount of time that they are given away from work. He insists that the trips that the experts undertake help them to forget their worries and have a peaceful moment to relax their minds as they prepare for the implementation of the next plans. Though the company has close to eighty affiliates in six states, it focuses on bringing all the members in the various areas together to enable them to share their ideas and views on the health sector.https://www.crunchbase.com/person/chris-steven-villanueva
The company is highly focused on providing the best services to its customers and is highly committed to accomplishing its mission through the unique strategies that it employs. MB2 believes in the art of innovation and pays a lot of attention in the factors that cause high competition in the market to derive measures to tackle them. Dr. Chris encourages his team of employees to practice team work to lead the company towards achieving its set goals.
Foresite Capital under the leadership of its CEO, Jim Tananbaum, continues to make major strides improving medical care as well promoting healthcare entrepreneurship. The moves are in an effort to provide a better understanding of the challenges mental health patients’ face and facilitate the improvement of services offered to them. One of the firm’s recent moves is through partnering with other investors such as ARCH Venture Partners, One Mind Brain Health Impact Fund and Optum Ventures which has seen a donation of $14 to Mindstrong Health. The Series-A funding given to the start-up will enhance delivery of objective measures in an effort to improve outcomes for patients with mental disorders.
In other hits by the CEO and Managing Director of Foresite, he helped Sierra Ventures to set-up its healthcare service investment practice. Further, he leads several other biopharmaceutical investments such as Amerigroup (IPO) and Amira Pharmaceuticals (acquired Bristol Myers-Squib). Tananbaum has close to 25 years of experience in healthcare and it’s even more important to note that he manages $1.1 billion in assets at Foresite. Jim Tananbaum holds an M.B.A from Harvard Business School as well as an M.D from Harvard Medical School. His career in the biopharmaceutical industry started after he finished studies at Harvard Medical School where he immediately founded Geltex Pharmaceuticals, which generates $1 billion in revenues as of today. Other start-ups in his early life include Theravance, Inc which together has brought together a market cap of $2.75 billion together with Theravance Biopharma, Inc. Visit Crunchbase to know more.
His current leadership at Foresite has led to tremendous growth of the firm which is based in San Francisco and has another office in New York. The firm issues growth capital to start-ups and growing healthcare providers in both private and public markets. The success of the company largely comes from Tananbaum’s main focus on strategic operations as well as financial openings to grow the healthcare industry. The most recent achievement has been his listing on the Forbes Midas List of top 100 venture capitalists. His success comes for the third consecutive year from what can be termed as a capitalist who makes huge and early bets in providing leadership to tech companies as well as exceptional value for upcoming investors. It remains interesting to see the next steps by the Dr. Jim Tananbaum in healthcare entrepreneurship as well as other investments.
See more: http://www.massdevice.com/neuropsych-treatment-diagnosis-platform-dev-mindstrong-health-raises-14m-series/
InnovaCare is a reputable provider of top-notch managed healthcare services in the U.S. It manages care for over 275,000 Medicare clients and over 270,000 commercial members via groundbreaking models. COO Penelope Kokkinides confirmed that InnovaCare specializes in two major types of care: establishing groundbreaking provider network models and delivering exemplary Medicare Advantage Plans. The firm manages two leading-edge Medicare Advantage Plans: PMC Medicare Choice and its affiliate firm MMM Healthcare.
MMM/PMC provides all-inclusive healthcare benefits to close to 218,000 beneficiaries. MMM optimizes the emotional and physical health of its clients through excellent care and value added programs. The high-profile National Committee for Quality Assurance (NCQA) awarded an Accreditation to the MMM. InnovaCare is a provider management firm responsible for managing the Puerto Rican MSO. It focuses on creating ACOs, models of care revolving around global risk and managed care, provider networks, and Patient-Centered Medical Homes.
CEO Richard Shinto
Shinto is a member of the InnovaCare’s executive team, holding the CEO post. He acted as the CEO and executive head of Aveta Inc. He was also a longtime member of Aveta’s management team. Currently, he oversees Puerto Rican Health Plans. He has been a clinical researcher and health management expert for the last two decades.
Before securing a senior role at Aveta, Shinto used to work for NAMM California as CMO. He also coordinated day-to-day activities of Medical Pathways Management Company as the CMO and COO. After relinquishing his position at Medical Management for MedPartners in 1997, Shinto joined California-headquartered Cal Optima Health Plan as the CMO. He completed his internship program at a health institution located in Southern California.
Education and authorship
Shinto obtained his B.S. from Irvine’s University of California. Later on, he earned his degree in medicine from State University of New York. He joined the University of Redlands and studied an MBA. Rick Shinto is a talented author who has written many articles, highlighting issues in clinical medicine and healthcare sector. Learn more about Rick on XRepublic.
Kokkinides rejoined the management team of InnovaCare as a chief administrative officer back in 2015. She had previously held the COO role of InnovaCare and Aveta. She is experienced in coordinating clinical operations and government programs. She seeks to optimize organizational infrastructure and boost efficiencies by supervising healthcare operational initiatives. While serving as the senior vice president as well as the COO of Centerlight Healthcare, Kokkinides handled overall management duties and oversaw strategic direction of the institution.
Read more about Rick Shinto on smartbrief.com
Mikhail Blagosklonny is a researcher of oncology. He is based in New York, at the Roswell Park Cancer Institute. Mikhail studied at the University of St. Petersburg where he graduated with his Medical Doctorate and Philosophy Degree. He particularly focused on cardiology and experimental medicine. After his studies, he was first appointed at New York Medical College as an associate professor. Afterwards, he joined Ordway Research Institute where he served as a senior scientist until 2009. During the same year, he was appointed to his current position at Roswell Park. Blagosklonny has deep interest in researching about cancer, its treatment, and developing drugs that can protect normal cells in the body. He also researches on aging-related diseases.
Blagosklonny is the chief editor of three widely read journals, which are Cell Cycle, Oncotarget and Aging. In addition, the scientist offers innovative insights to Cell Death and Differentiation where he serves on the editorial board. He has also made significant contributions at Cancer Biology and Therapy where he is an associate editor. Moreover, he has published more than 270 papers in varied journals where he has listed citations that exceed 25,000. Blagosklonny has a wide range of skills relating to Cancer Therapy, Apoptosis, Cancer Cell Biology, Signal Transduction, Protein Kinases, Cell Proliferation, Phosphorylation, and Cell Division among others.
At Cancer Institute of Roswell Park, Mikhail Blagosklonny has used his transformative style of leadership to enhance the growth of the institution. He has managed to expand the methods of cancer prevention, treatment and other anticancer strategies. He has also shared many ideas with other members at the institution, including the different ways of protecting normal cells from electrochemical therapies and special tissue treatment. Additionally, Mikhail has made significant contributions on the right combination of cancer drugs and mechanisms of slowing down the aging of organisms through cancer prevention. Read more on Impact Journals.
Blagosklonny is a well-known researcher who has developed exceptional methods of cancer prevention and treatment. He has extended his research to include the treatment of cancer and aging-related diseases. His publications have been of great help to the company, scientists, readers and the public at large. As a professor of oncology, Mikhail continues to engage in extensive research processes.
The Capitol Anesthesiology Association has been providing care since 1973 to patients who need anesthesia. The team of over 80 physicians and 130 Registered Nurses specializing in providing anesthesia for a variety of patients including individuals who need obstetric, pediatric, and cardiothoracic care. The team is made up of anesthesia specialists from over 20 facilities in Austin TX. They are committed to providing anesthesia that meets the highest quality standards and the professionals make sure that their patients feel comfortable and secure.
Many services are provided by Capitol Anesthesiology Association including general anesthesia, local anesthesia, and regional anesthesia. General anesthesia is performed when patients are having major surgery and need to be completely unaware of their surroundings. Regional anesthesia is performed when one area of the body need to be operated on such as an arm or leg. Local anesthesia or Monitored Anesthesia Care is a controlled anesthesia experience where local anesthetics are provided in the tissues and skin that surround the area to be operated on. More anesthesia is supplied as needed and a patient’s level of consciousness will be appropriately adjusted.
For more information about Capitol Anesthesiology, check out: http://www.medpagetoday.com/anesthesiology/anesthesiology/62062